Concepedia

Karine Jeanneau

KJ

5

Publications

631

Citations

5

H-Index

2005

Active since

Affiliations

Roche (Switzerland)(Current)

Novartis (Switzerland)

Karine Jeanneau is an author at Roche (Switzerland) specializing in medicine, neuroscience, and social sciences.

Top concepts

Publications per year

2005–2014

5

Publications

5

Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity

Lothar Lindemann, Claas A. Meyer, Karine Jeanneau et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 347 citations

Brain-Specific Overexpression of Trace Amine-Associated Receptor 1 Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine

Florent G. Revel, Claas A. Meyer, Amyaouch Bradaïa et al. · Neuropsychopharmacology · 2012 · 114 citations · Full text

, , +11

The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes

Gaëlle Elain, Karine Jeanneau, Aleksandra Rutkowska et al. · Glia · 2014 · 70 citations

Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia

Céline Risterucci, Karine Jeanneau, Stephanie Schöppenthau et al. · Psychopharmacology · 2005 · 56 citations

, , +11

Dimorphic Effects of Leptin on the Circadian and Hypocretinergic Systems of Mice

Jorge Mendoza, C. López-López, F. Revel et al. · Journal of Neuroendocrinology · 2010 · 44 citations

, , +27

Rows per page

1–5 of 5